Glycochenodeoxycholic acid inhibits calcium
phosphate precipitation in vitro by preventing
the transformation of amorphous calcium
phosphate to calcium hydroxyapatite.
S M Qiu, … , N K Hong, R S Crowther
J Clin Invest. 1991;88(4):1265-1271. https://doi.org/10.1172/JCI115430.
Calcium hydroxyapatite can be a significant component of black pigment gallstones. Diverse molecules that bind calcium phosphate inhibit hydroxyapatite precipitation. Because glycine-conjugated bile acids, but not their taurine counterparts, bind calcium phosphate, we studied whether glycochenodeoxycholic acid inhibits calcium hydroxyapatite formation. Glycochenodeoxycholic acid (2 mM) totally inhibited transformation of amorphous calcium phosphate microprecipitates to macroscopic crystalline calcium hydroxyapatite. This inhibition was not mediated by decreased Ca2+ activity. Taurocholic acid (2-12 mM) did not affect hydroxyapatite formation, but antagonized glycochenodeoxycholic acid. Both amorphous and crystalline precipitates contained a surface fraction relatively rich in
phosphate. The surface phosphate content was diminish by increasing
glycochenodeoxycholic acid concentrations, and this relationship was interpreted as competition between bile acid and HPO4(-4) for binding sites on the calcium phosphate surface. A phosphate-rich crystal surface was associated with rapid transition from amorphous to crystalline states. These results indicate that glycochenodeoxycholic acid prevents transformation of amorphous calcium phosphate to crystalline hydroxyapatite by competitively inhibiting the accumulation of phosphate on the crystal embryo surface.
Research Article
Find the latest version:
http://jci.me/115430/pdf
Glycochenodeoxycholic
Acid Inhibits Calcium
Phosphate
Precipitation In Vitro by Preventing
the Transformation
of
Amorphous
Calcium Phosphate
to
Calcium
Hydroxyapatite
Sul-Min Qiu,GaryWen, NobuyukiHirakawa, Roger D. Soloway, Nan-KangHong, and Roger S. Crowther
Division of Gastroenterology, Department ofInternal Medicine, UniversityofTexasMedical Branch, Galveston, Texas 77550
Abstract
Calcium hydroxyapatite can be a significant component of blackpigmentgallstones. Diverse molecules that bind calcium phosphate inhibit hydroxyapatite precipitation. Because
gly-cine-conjugatedbile acids, but not their taurine counterparts,
bindcalcium phosphate, we studied whether
glycochenodeoxy-cholic acid inhibits calcium hydroxyapatiteformation.
Glyco-chenodeoxycholic acid (2 mM)totallyinhibited transformation ofamorphouscalciumphosphate microprecipitates to
macro-scopic crystalline calciumhydroxyapatite. This inhibition was notmediatedby decreased
Ca2"
activity. Taurocholic acid(2-12 mM) didnotaffect hydroxyapatite formation, but
antago-nizedglycochenodeoxycholic acid.Both amorphous and
crys-talline precipitates containedasurfacefraction relatively rich in phosphate. The surface phosphate content was diminished
by increasing glycochenodeoxycholic acid concentrations, and
this relationship wasinterpreted ascompetition betweenbile acid andHPO2- for binding sites on the calcium phosphate
surface.Aphosphate-richcrystal surfacewasassociatedwith
rapid transition from amorphous to crystalline states. These
results indicate that glycochenodeoxycholic acid prevents
transformation of amorphous calcium phosphatetocrystalline hydroxyapatitebycompetitively inhibiting the accumulation of
phosphate on the crystal embryo surface. (J. Clin. Invest. 1991.88:1265-1271.) Keywords:bile salts*biomineralization
*calcification*Fourier transform infraredspectroscopy *
gall-stones
Introduction
Calcium salts ofbilirubin, fatty acids, carbonate, and
phos-phate are important constituents ofall classes of gallstones, although the predominant saltvaries with the type ofstone(1,
2).Thefundamental drive for thesesaltstoprecipitatecanbe
understoodonaphysicochemicalbasisasthesolubility prod-uct fora particular salt beingexceeded. However, many of
Part of this work hasappearedinabstract form(1990.
Gastroenterol-ogy.98:A258).
Dr.QiuisaVisitingScientist from theDepartment of
Hepatobili-arySurgery, FirstAffiliated Hospital,Xian MedicalUniversity, Peo-ple'sRepublicofChina.
Addressreprint requeststo Dr.Crowther, Gastroenterology
Divi-sion,4.106McCullough Building, G-64, UniversityofTexasMedical Branch, Galveston,TX77550.
Receivedfor publication 1I December1990andinrevisedform24 June 1991.
thesespeciesexist in normal bile in supersaturated
concentra-tions,but do notprecipitate.It isbecoming apparent that other componentsof bilecaninteractwith these species in ways that
modify theirprecipitation, and specific modifying factors such
asacidicglycoproteins(3) andbile acids(4) have been identi-fied.
Ourinterest inthepathogenesis ofpigment stones has led
ustostudy factorscapable of influencingtheprecipitationof
calciumhydroxyapatite,
Cal0(OH)2(P04)6,
(HAP),' which, al-though it isarelativelyuncommon gallstone component, cancompriseup to 30%ofthe total massofblackpigmentstones (2). Sutor and Percival (5) demonstrated that human common
ductandgallbladder biles from subjects with cholesterolstones
containedfactorsthatinhibited calciumphosphate precipita-tion, and they proposed that bile salt/phospholipid micelles
wereresponsible for this effect. Hydroxyapatite is formed from amorphous calcium phosphate (ACP) bydissolution and
re-precipitation (6). ACPmay havethe stoichiometry of dical-cium phosphate dihydrate, CaHPO4. 2H20, ortricaldical-cium
phos-phate, Ca3(PO4)2-XH20,depending on theformation condi-tions. Ithas been shownthatbileacidscanbindtoACPand thatdifferent bile acidshavemarkedly different affinities (7).
Glycine-conjugated dihydroxy bile acids showed the highest affinity, whereasalltaurineconjugates showedalmostno abil-itytobind.
Wehypothesizedthat theeffectsseenby SutorandPercival (5) could be caused by bile acids bindingtocalcium phosphate microprecipitates, thereby preventing furtherprecipitation.To
test this,we studiedthe effects ofa glycine-conjugated
dihy-droxy bile acid, glycochenodeoxycholic (GCDC), anda
tau-rine-conjugated trihydroxy bileacid,taurocholic (TC), which
we predictedtobe active andinactive, respectively, with
re-specttotheinhibitionofhydroxyapatite precipitation.
Methods
Materials.Calciumchloride,dibasic sodiumphosphate, Trizma-HCl,
Trizma-base, calciumhydroxyapatite(typeI),bileacids(sodium salts),
and murexidewerepurchased fromSigmaChemicalCo.,St. Louis,
MO.Diphenylhexatrieneandtetrahydrofuranwereobtained from
Al-drichChemicalCo., Milwaukee,WI.
Stock solutions. Five stock solutionswerepreparedforusein all
experiments: (a)500 mM Tris-HCl and Tris-basebuffer,pH7.50;(b)
100mMcalciumchloride; (c)100mMdibasic sodiumphosphate;(d)
100mMbileacid;and(e)1.5 Msodiumchloride.
Calcium phosphate formation. Solutions containing calcium or
phosphatewereprepared separately.Finalconcentrations in each solu-tionwere:8 mM calciumor8 mMphosphate,50 mM Trisbuffer,0-80 1.Abbreviationsusedin thispaper: ACP, amorphouscalcium
phos-phate; CMC, critical micelleconcentration; FTIR,Fourier transform infrared; GCDC,glycochenodeoxycholic acid; HAP,calcium hydroxy-apatite; It,inductiontime;TC,taurocholic acid.
J.Clin.Invest.
©The American SocietyforClinicalInvestigation,Inc.
0021-9738/91/10/1265/07 $2.00
mMbile acid, andsufficient sodium chloride to let =0.15, in atotal volume of10 ml. Each solution was titrated to pH 7.50, passed through a0.22-,gmfilter(Micro Separation Inc., Westborough, MA), and equili-brated at370Cfor 20 min. During this time the pH fell from 7.50 to 7.31±0.02. To start thereaction, we mixed equal volumes of calcium-andphosphate-containing solutions, so that the initial concentration of each reactant was 4 mM. These concentrations were used by Sutor and Percival (5) and result inprecipitation within a convenient time scale. The mixed solutions were placed in quartz cuvettes maintained at
370C,and theformation of calcium phosphate was monitored turbidi-metrically at 220 nm (8) (model 4053 spectrophotometer, Biochrom, Cambridge, England). In some experiments an aliquot of 500
.d
was withdrawn after 22 h of incubation and centrifuged for 5 min at 1 1,000 g, and the supernatanttotal calcium and phosphate content was deter-mined.Determinationof total calciumandphosphate. Total calcium was measured by atomicabsorption spectrophotometry (model 5 100, Per-kin-Elmer Corp., Norwalk, CT) after dilution of samples with 5% tri-chloracetic acid/ 1% lanthanum chloride. Phosphate was determined by
conductivitymeasurementafter ion exchange HPLC (Ionpac AS4A
column, Dionex, Sunnyvale, CA) or by the molybdenum blue method(9).
Fourier transform infrared spectroscopy (FTIR). Calcium- and phosphate-containingsolutions, with or without bile salts, were mixed andplaced in an attenuated total reflectance cell fitted with a zinc selenide crystal (CIRcle cell, Spectra-Tech, Inc., Stamford, CT) and mounted in anFTIRspectrometer (model FTS 60,Digilab,Boston, MA). Spectra were collected atintervals for up to 72 h. The spectrum of areferencesolution, whichconsisted of 50 mM Tris,4mMCa2",and
100mMNaCl,wasmanually subtractedfrom each sample spectrum to disclose the signal from the precipitate. Spectra were not corrected for phosphate because the absorbancefrom precipitates was at least 20 times greater than the absorbance of4 mMphosphate.
Determinationofbileacidcriticalmicelle concentration (CMC).
The CMCs of bile acids were measuredfluorimetrically (10).1 41of 10 mMdiphenylhexatriene intetrahydrofuranwasaddedtodifferent con-centrations of bile acids dissolved inatotal volumeof 2 ml of Tris-buf-feredsolution,pH 7.5,g=0.15. Tubeswereincubated in the darkat
roomtemperature for 30 min. Fluorescencewasmeasuredat an excita-tionwavelength of 358 nmandan emissionwavelengthof 430nm
(modelLS-5B luminescencespectrometer,Perkin-Elmer Corp.). Effectofbileacids on Ca2" activity. Calcium activitywas
deter-minedwith the calcium-sensitive indicator murexide. The absorbance ofcalcium-containing solutions at540 and 470 nm wasmeasured
againstreference solutions thatwereof thesamecomposition,
includ-ingbile acid whenappropriate,butweredeprivedof calcium(I 1).In this way the effect of any shift in thedyeabsorbance spectrum caused by bileacid-dyeinteractionwasminimized. Thedifference in absor-banceatthetwowavelengthswaslinearlyrelatedtothelogarithmof calciumactivity.
Results
Calciumphosphateformationinthe absenceofbilesalt. When
theformation of calciumphosphatewasmonitoredby
turbid-ity measurement, a typical curve (Fig. 1) comprised three phases:(1)aninitial steady increaseinturbidity,which
gradu-ally slowed; (2)asuddenrapidincreaseinturbidity,whichwas
initiatedat56.6±4.7min(mean±SD,n=5);and(3)agradual
decline in turbidity aslarge particles sedimented. WhenpH
was monitored, there was an initialrapid fallof - 0.03 pH
units that was probably caused by the formation ofsoluble
Ca2`/HPO'
complexes.Throughouttheremainder ofphase 1thepHfellafurther 0.01 pHunits,andthen, simultaneously
with the onset of phase 2, the pH of the solution declined sharply(Fig. 1),indicatingthattheeventsofphase2involved
z
0.
E
CD'
I-Time, min
Figure1.Formation ofcalcium phosphate monitored by turbidity and pH.Ca2"and phosphate (4 mM final concentration of each) were mixed togetheratpH7.3,,u=0.15,370C,andformation of
precipi-tate wasmonitored either byturbidity(o)orpH(-) measurements.
precipitationofadditional calciumphosphate, notsimply ag-gregation of existing material. These curves are similar to those
seenby otherinvestigators ( 12).The onset ofrapid
precipita-tion has been associated with the transformation of ACP to
HAPand thetimerequired for thistooccurhas beentermed the induction time
(Ij)
(12).Effect
of bile acids on the precipitation ofcalcium phos-phate. GCDC at a concentrationof 0.5 mM reducedIt
by- 15 min, but withincreasingGCDC concentrations
It
wasprogressively lengthened,until at aconcentration of 2 mM and above, phase 1wasprolongedfor5h, at whichpointthe experi-ment wasterminated(Fig. 2). Additionalexperimentsshowed that when the concentration of GCDCwas2 2mM,therewas
nomarkedincreaseinturbidity andnovisibleprecipitate,even after 4 d(notshown). Measurement of supernatant calcium
0.8
E CD
10
I-0 100 200
Time, min
300
Figure2.Effect ofGCDConcalciumphosphateformation.
Ca2"
andphosphateweremixedtogetherunder thestandardconditions,either without(o)orwith 0.5mM(-), 1.0mM(o), 1.5mM(n),2.0 mM(A), 4.0 mM(A),8.0mM(o),or12.0mM(x) GCDC;formation of
pre-cipitatewasmonitoredbyturbidity.Theportionsof thecurves
and phosphate concentrations after22 h demonstrated that, as well asincreasing
It,
GCDC also decreased the total amount ofcalcium phosphate precipitated. In the absence of GCDC 7.52±0.03
,mol
of calcium wasprecipitated,andthis waspro-gressively reduced by 0.5 mM (7.48±0.08), 1.0 mM
(6.76±0.11), 1.5 mM (6.29±0.03), and 2 mM (0.74±0.60)
GCDC.Similar resultswereobtained forphosphate
precipita-tion.Theseexperimentsclearly show that GCDC causes
con-centration-dependent inhibitionofcalcium phosphate
precipi-tation.
The effects of TC were minor compared with those of
GCDC. Therewassomevariation inI,but values were always
within20% ofthecontrol: 0 mM, 55 min;2mM, 55 min;4
mM, 45min;9 mM, 47min;12 mM, 62min.
Theeffect of GCDCand TCin combinationwas also
stud-ied.When a lowconcentration ofGCDC (1.5 mM) was mixed
with increasing concentrations ofTC(2-12 mM),
I,
decreasedexponentiallyastheamountof TC increased (Fig. 3). Interest-ingly, compared with 1.5 mM GCDC alone, the lowest TC
concentration increased It (164 and 317 min, respectively). Similar effectswereobserved withahigher GCDC
concentra-tion(4 mM) andTC varyingbetween 2 and 12 mM (Table I).
Although TC concentrations of2 and 4 mM plus 4 mMGCDC postponed phase2longer thantheduration oftheexperiment (500 min), the turbidity readings during phase 1 indicateda
fasterprecipitation ratethan when 4 mM GCDC alone was present(TableI).
CMCofbile acids. The CMCs of GCDC and TC were
de-termined to be 2 and 8 mM, respectively. These values are
consistentwith previousreports(13) andwereunaffectedby thepresenceof either4 mMCa2+or 4 mMphosphate.
How-ever,sincethis method isrelativelyinsensitivetosubmicellar
aggregates,itcannotbe ruledoutthat theseionsmayinfluence thesizeornumberof submicellaroligomers. Experimentswere
also performed to study the state ofaggregation of systems
containingbothGCDC and TC. Whenincreasingamountsof TCwereaddedto 1.5 mM GCDC, TCbecameincorporated into mixedspeciesaggregates, and the"CMC"for this mixed
systemwasestimatedtobe 4 mM total bilesalts, but this value will dependupontheGCDC/TC ratio. Thus, the addi-tion of2 mMTCto 1.5 mMGCDCincreased theamountof
system aggregation (eithernumberor sizeofaggregates) and
therebyprovidedmoreeffectiveinhibitionofHAPformation,
resulting in theprolonged
I,
shown inFig.3.As moreTCwasadded, theaggregatescontainedevergreaterproportionsofTC,
Figure3. Correlationof 400 inductiontime with
GCDC/TCratio.Ca2+ andphosphatewere
S 300. mixedtogetherunder E thestandard conditions
E2
together with 1.5 mM200 GCDC and various
concentrations of TC
(2-12 mM). Values ofI, X 100 * weremeasured from
plots ofturbidity against
time. Arrow indicates
o. . . I,forasystem
contain-0 2 4 6 8 10 12 14 ing 1.5 mM GCDC and TCconcentratlon,mM noTC.
Table I. Effect of GCDC and TC in Combination on Calcium Phosphate Formation
Phase 1
[GCDC+TC] precipitation rate It
mM AOD/h min
0+0 0.749 50
4 +0 0.022 >500
4+2 0.025 >500
4 + 4 0.044 >500
4+9 0.055 250
4 + 12 0.076 82
0+ 12 0.872 62
Ca2" andphosphate (4 mM final concentration of each) were mixed together, with or without4 mMGCDC andincreasing concentrations
ofTC,atpH 7.3,j =0.15,
370C;
formationofprecipitatewasmoni-tored by turbidity at 220 nm.Precipitationrateand
Ih
were deter-minedfrom plots of turbidity against time.andthiswasresponsible for the decreased inhibition seen in Fig. 3. This mechanism also operated when the GCDC
concen-tration was 4 mM and resulted in the attenuated inhibition shown in TableI.
Because potentinhibitionwasachievedatGCDC
concen-trations that approximated the CMC, it seemed likely that small aggregates, perhaps dimers, rather than micelles, were
responsible for this action.To testthispossibility,weexamined the effect ofdehydrocholicacidon HAPformation,since
dehy-drocholic acid does not formmicelles, butcan form dimers
(14).Underconditions ofconstantionic strength, dehydrocho-lic acidcaused modest inhibition ofHAP formation: in the absence ofdehydrocholic acid 4.72±0.08
Mmol
ofphosphatewereprecipitatedat 24h,and thiswasprogressively reduced by 20mM(4.61±0.09), 40mM(4.21±0.01),60mM(3.81±0.06),
and 80mM(3.40±0.13) dehydrocholicacid.
Effect of bile acidson
Ca2"
activity. Under conditions ofconstantionic strength, both TC and GCDC reducedCa2+ ac-tivity,but GCDCwas moreeffective thanwasTC(not shown).
GCDC concentrations <4 mMhadnomeasurable effecton
Ca2+
activity, and GCDC concentrations of4and 20mMre-ducedactivity by only5%and25%, respectively.Even witha
25% reduction inactivity,thesolutions wouldremainhighly supersaturatedwithrespecttoHAP, and theeffect of GCDC
must be mediated by an alternative mechanism. TC had a
lesser effecton
Ca2+
activity,anda20mMsolution decreasedactivitybyonly6%.
Dehydrocholic
acid reducedCa2+activity
by4% (20 mM), 5% (40 mM), 14% (60 mM),and 20%
(80
mM). There was aclosecorrelation between
Ca2`
activity
in thepresence ofdehydrocholicacid andthe amountofHAPprecipitated
(r2
=0.958,P<0.005).FTIRstudies
of
calciumphosphateformation.
Todemon-stratethatphase2wasassociated with theformationofHAP,
weanalyzed the products ofthe reaction in situbyFTIR.Inthe absence ofbile acid, the
precipitation
of calciumphosphate
caused theintensity of the orthophosphate
(P-O)
absorption
bandat 1,150-950
cm-'
toincrease with atimedependency
that was verysimilartotheturbiditycurvesproduced
inearlierexperments,
except that I wasincreased from 56 to80 mina)
0 0 co m 0 V) 0 0o
0
co
1.6
1.4
ECD
CM
.0
I-0 100 200 300
Time, min
Figure 4.Formation of calcium phosphate monitored byFTIR spec-troscopy.Ca2" andphosphate were mixed together under the standard
conditions,except thatthe temperature was 30'C, and precipitation wasmonitored by either FTIR spectroscopy(e)orturbidity (o).
30±1'C, and when a turbidity experiment was repeated at
30'C,the two setsofmeasurementscorrelated exactly (Fig. 4).
Concurrently withthe onsetof phase 2,the IRabsorption spec-trumof the calcium phosphateunderwent aprominent change
(Fig. 5A).Before phase2 the orthophosphate absorption band was relatively symmetrical, indicating little distortion of the phosphateionsfrom an average tetrahedral symmetry, which is
typicalof ACP
(15).
Butbetween 85 and 95min(i.e., 5min afterIt),
thephosphate peakbegan totransform intoatriplet (Fig. 5 A), which indicated that certain P-O vibrations werebeingselectively restricted byanewlyforming crystalstructure. By240min the spectrum wasconsistent withthebulkofthe
precipitate beingHAP, asjudgedbycomparison withan
au-thenticHAP standard(Fig. 5 A, inset). Thusphase 2is
asso-ciated withthe emergenceofHAP asthepredominantform of precipitated calcium phosphate. Thepredominance ofHAP
couldexplainthegreatly increasedrateofprecipitationatthat
time,becauseHAPis muchless soluble than are otherforms of calcium phosphate (16).
As wouldbe predicted from earlierexperiments, 12 mM
TC hadlittleeffectonthe FTIR spectra, although
I,
and theappearanceofthephosphatetripletwereprolongedto - 1 10
min(not shown), which is consistent with the minordelaying effectpreviouslyseenwiththis concentration of TC (Table I). GCDC, however, had considerable concentration-dependent
effectsonthe IR spectraascalciumphosphateprecipitated.At 2 mM, GCDC completely prevented the appearance ofthe
crystalline phosphate triplet, although amorphous material continuedtoform slowly(Fig. 5B).In contrastwiththe
con-trol, wherethelocationofthe maximum absorbance moved progressively to lower wavenumbers throughout the
experi-ment, in the presenceof2 mMGCDC thepeak didnotshiftat
all, whichsuggestsveryeffective inhibition of transformation. Nocrystallinematerialwasdetectedat3d,atwhichpointthe
experimentwasterminated. Thus,theeffect of GCDC is
me-diated by preventingthetransition ofACPmicroprecipitatesto macroscopic crystallineHAP. With 1 mM GCDC,the
phos-phate triplet appeared at 85 min (notshown), and 0.5 mM GCDCaccelerated theappearanceof thetriplet,which became
1.2
1.0
0C)
Cu co
D0
0.8
.0
CDen0.6
-
0.4-
0.2-0.0
1200
K
0.3
1200 800
0.2
0.1
0.0
800
B
1200
800
Wavenumbers
(Cm-')
Figure 5. Effect of GCDConthe FTIRspectrumof maturing calcium phosphate. Calcium and phosphateweremixed and examinedas
de-scribed inFig.4.Spectrawereobtained(A)inthe absenceofGCDC
at(a)5min,(b) 85min,(c) 95min,(d)240min;or(B)inthe
pres-enceof 2 mMGCDCat(a)1h, (b) 5 h, (c) 48 h, (d) 72 h.Theinset
in Ashows the IRspectrumofstandard HAP. The sharp unresolved peaksat1,075cm-' in Barecaused by GCDC.
visible by 75 min (not shown). Otherwise the precipitation pro-cessdidnotmarkedly differ from the control situation,which
wasagain consistent with earlier observations (Fig. 2).
Effect ofGCDConthestoichiometry ofcalcium phosphate
precipitates.TheFTIRspectrumof controlprecipitatesafter
I,
wasverysimilar, butnotidentical,tothespectrumofthe HAP standard, which suggested that nonapatite material may becontainedintheprecipitate. Precipitateswerecollectedby
fil-tration(0.22
,gm)
30min beforeIt(phase 1)andby centrifuga-tion 30 min afterI,
(phase 3). Half of each precipitate waswashed with10mlof10mMTrisbuffer, pH 7.50andwashed
and unwashed precipitateswereanalyzedfor calcium and phos-phoruscontent(Table II). Theunwashedphase1 precipitates
allhadCa/Pratios closeto1,which indicated thatmostofthe
phosphatewaspresentas
HPO4'-.
TheCa/Pratio of unwashedphase 1 precipitates increasedwithincreasingGCDC
concen-tration.Washingthephase1precipitatescaused theCa/Pratio
toincrease, suggestingthat the interior oftheparticleswas
rela-tively less rich in HPO-, although this must bea tentative
interpretation because thesmallamountof materialremaining after washing resulted in relatively large errors. The washed
Table II.EffectofGCDC on Ca/P Ratios (Mean±SD) ofWashed and Unwashed Precipitates
fromPhasesIand 3
Phase I Phase 3
GCDC Unwashed Washed Unwashed Washed
mm
0 1.00± 0.07 1.19±0.14* 1.66±0.02 1.73±0.03*
0.5 1.00±0.06 1.22±0.18* 1.55±0.02 1.69+0.041 1.0 1.05±0.08 1.26 1.67±0.05 1.71±0.05* 1.5 1.05±0.08 ND 1.71±0.03 1.71±0.04* 2.0 1.18±0.05 1.50
Ca2+
andphosphate (4 mM finalconcentration of each) andincreas-ing concentrations of GCDC were mixed together at pH 7.3,u=0.15,
370C.Precipitates were collected both 30 min before (phase 1) and 30 min after (phase 3)I,.Precipitateswereanalyzedeither before or
afterwashingwith 10 mMTris,pH 7.5. Insomecases,onlyone washedphase I sample was assayed because of losses during washing. Where SD values are given, at least three samples were assayed.
Significancebetween washed and unwashed sampleswasassessedby ttest:*NS;$P<0.05;§P<0.005.
Inthecontrolphase 3 precipitates, washingcaused theCa/P ratiotoincrease,which suggested thatasurface layer, relatively rich in phosphate, had been removed from the precipitate. GCDC, 0.5 mM, decreased the Ca/P ratio ofunwashed phase3
precipitates in comparison withthecontrol, but1 and 1.5 mM
GCDC progressively increased theCa/Pratio, until with 1.5 mMGCDCunwashed andwashedprecipitatesdidnotdiffer.
From these data we calculated the Ca/P ratio of the surface fractions removed bywashing from phase 3precipitates,and plotted this ratio against induction time(Fig. 6). AlowCa/P ratio(i.e.,phosphate-rich surfacefraction)wasassociated with
ashortI,and astheratioapproachedthevalueforHAP(1.67),
verysmallchanges in compositionwerecorrelated with large changes in
I,.
Discussion
Exceptunderverydiluteconditions(17)theformation ofHAP
proceedsthroughatransitional ACPphase(18) byaprocessof dissolution andreprecipitation (6),rather than
by
solid-phaseFigure 6. Correlation of induction time with the Ca/Pratio of hydroxy-apatitesurface fraction. Thecomposition of the surface fraction of hy-droxyapatites formed in thepresenceof increas-ingconcentrations of GCDC(0-1.5 mM)was calculatedfrom the data in Table II and plotted against values of induc-tiontime obtained from
n turbidity measurements.
transition (19), and the rate ofconversion is proportional to the crystal content of the precipitate (20). The precise structural detail and chemical composition ofboth ACP and its transition products vary considerably (18, 21-23). Our results clearly showthat lowconcentrations (- 2 mM) of GCDC, but not TC,strongly inhibit thetransformation of ACP to HAP. Al-though bile acids reduce
Ca2"
activity (24, 25), and glycine-conjugated bile acids are more effective than taurine conju-gates (25), this is not the mechanism bywhich GCDC pre-vented HAP formation, since inhibition occurred at GCDC concentrations that did not measurably affectCa2"
activity.A range of molecules and ions, including proteoglycans (26); phytates (27);
Mg2e,
Sr2",
andZn2`
(28); ATP(29); pyro-phosphate (28, 30); casein (31); andphospholipids(32),inhibitHAP formation. Williams and Sallis (33) proposed that the
minimum requirement forstronginhibition by anionic species
is thepossession of one phosphate group and one otheracidic
group,which may be either phosphate or carboxylic acid.
Mole-culeswith multiplecarboxylicgroupsalsoinhibit,but the min-imumnumberofgroupsrequiredisunknown (34).Inhibition ofHAPformationbyGCDCappearsreasonable because in the
aggregated state GCDC shouldmimicapolycarboxylated
mole-cule. The needfor multiple carboxylgroups suggeststhat the action ofsubmicellar concentrations ofGCDCrequiresdimers
orhigher multimers. That GCDC caused potent inhibition at 2
mM,aconcentrationatwhichveryfew micelles would be antic-ipated,alsosuggestssubmicellar multimers may betheactive species. Experiments withdehydrocholic acid confirmed that
partial inhibition could becausedby bile aciddimers, but80
mM dehydrocholic acid was much less effective than 2 mM
GCDC, and, unlike GCDC, the effect ofdehydrocholic acid
wasassociatedwithreduced
Ca2"
activity. The effect of dehy-drocholic acidonCa2"
activitywas unexpected.Taurodehy-drocholicacid does not affect
Ca2"
activityasmeasuredbytheCa2"-sensitive
electrode (35),andthereforethe presentresultsmay reflect our use of different methodology for measuring
Ca2+ activity (1 1).Itisunknownwhether thegreaterinhibiting
powerof GCDC derivesfrom its ability to form higher
mul-timers,orfromspecificstructuraldifferences thatmay enhance theability of GCDC dimers tointeract with HAP.
Dehydro-cholicacid differs from GCDCintwoimportantways: thering
substituents are equatorial keto groups rather than axial
hy-droxylgroups, and the carboxyl-bearingside-chain is shorter. The presenceof hydroxylgroups inGCDCmaybeimportant,
since citric acid isaninhibitorofHAPformation, althoughits dehydroxyl and dehydro derivatives are inactive (36). The
current data do not allow a definite conclusionto be
drawn
about thesize oftheGCDCaggregaterequiredtoinhibitHAP
formation.
Williams and Sallis (12) proposed that most inhibitors
could bedivided intotwoclasses: type Iactprincipally by
bind-ingto HAPcrystalembryosandpoisoning them;type II func-tion bydecreasing the labilityof ACP. Bothtypes
delay
HAPformation, but only type I inhibitors reduce the amount of HAPformed(12). Because GCDC both delayed and reduced theproductionofHAP,thisbileacid isatype I inhibitor. This
conclusion is consistentwithourobservation that GCDC hasa
higheraffinityforHAPthanforACP(Qiu, unpublished
obser-vations).
Both ACP andHAP containHPO2--richsurfacefractions that can beremovedbywashing (18). The difference in
Ca/P
ratios between unwashed and washed
hydroxyapatites
was a
1.8-
1.7-
1.6-1.5
1.4
1.3-c 0 7.
O
Lo
0 O
.2
a.
. *
C)
1.21
-25 75 125
function of GCDCconcentration, and the amount of surface phosphateintheprecipitatewas reduced by GCDC
concentra-tions >0.5 mM. The amount of surfacephosphate could be reducedeitherbystabilization,so that it could not be removed
bywashing,orbyinhibition oftheinitial accumulation of acid
phosphateontheparticle surface.The general upward trend in
theCa/P ratio of unwashed precipitates withincreasing GCDC
concentration supports the second interpretation. We have
shown that GCDCbindingto HAPis inhibitedby
HPO4-,
but not byH2PO4?,suggestingthat GCDC andHPO-compete for commonbinding sites(37). Such competition for binding sites onnewly formedHAPembryos should poisonthe crystalsur-face. This competition is reflected in our observation that a
phosphate-richsurfacefraction iscorrelated with a shortI.At
lowGCDC concentrations, the competition may be enough
onlytoslow therateof crystal growth,but athigher
concentra-tions, becauseofan increase in either the sizeor numberof
aggregates,thedegreeofpoisoningmaybeso great that growth
ispreventedandthe HAP embryosredissolvebefore they
con-stituteasufficient fractionof the total calciumphosphate
pre-cipitatetobe detected by FTIR. Tothe observerthisprocess
wouldappear asstabilization ofthe amorphous state.
Itis unknown why GCDCshows greaterbindingthan TC toACP (7) and HAP(38). However, because all the glycine-conjugated bile acids investigated, as well as unconjugated deoxycholic acid, bound to amuch greater extentthan any
taurineconjugate,acarboxylicacidgroup mayfavor binding (7). Inaddition, glycocholic acid boundtoACP(7) and HAP
(38) less well than did theglycine-conjugated dihydroxy bile
acids,thus theineffectivenessofTCmaybe relatedtobothits
conjugationanditshydroxylationpattern.Theincreased affin-ity of
Ca2"
forglycine conjugatesovertaurine conjugates has beenattributedto moreextensivehydrationof the latter (25).However,in thepresentsituation bile acidbinding isnot
occur-ringtoisolated
Ca2"
ions insolution,but rathertotheHAPsurface, which consists ofregionsofalternating positive and
negativepolarity. Therefore, ifadjacentanionicgroupsofthe
bile acid aggregate are not arrayed in a mannerthatbrings
themintoappositionwithregionsofpositive polarity, theywill likely interact withnegativelychargedareas and be repelled. Underthisscenario,GCDCaggregates possessanionicgroups
thatmirror the spacing ofcalcium ionsontheHAPsurface,
whereas the sulphonate groups of TC aggregates are
mis-aligned.Inexperimentswith mixedTC/GCDCsolutions,TC
was incorporated into GCDCaggregates and attenuated the
inhibitionofHAPformation. This effect isprobably causedby increasingamounts ofTCinducingprogressively severe
mis-alignmentofanionicgroups. Theobservation that the action of
agivensubmicellarconcentration ofGCDCcanbeaugmented
by smallamountsof TCsufficientto causeincreased bile acid
aggregation indicates that the deleterious effects of small amounts of TCareinsufficienttooffset theadvantage of in-creasedaggregation.
Theability ofmixedTC/lecithinmicellestoinhibit calcium phosphate formation (5) isprobablycausedbybindingtoACP
orHAPnuclei initiatedbythe
lipid
phosphategroups.TC and othertaurine-conjugated bileacids,
aswellasGCDC,
inhibittheprecipitationof calcium bilirubinate(4, 39). Thefact that
somebile acidsinhibit
precipitation
of onlysomecalcium salts (TCcaninhibit calciumbilirubinate,but notHAP)again sug-geststhatinhibition ofcalcium saltprecipitationdoesnot neces-sarilyoccur asaresult of direct actiononthecommoncation,
calcium,in solution.In someinstancesinhibitionmaybe
me-diatedby specificinteractions between the bile acid and the
anion, either in solution or in a microprecipitate. In other cases,thetarget maybecalcium ionsincorporated intoa
crys-talembryo. Thespacingof these calcium ions isafunction of
crystaltype, sosmalldifferencesin thestructuresofaggregates
ofdifferent bile saltsmay meanthattheanionicgroupsinany
givenbile saltaggregate areoptimally alignedtointeract
prefer-entiallywith the calcium ionsofaparticularcrystal. If this is
true,changesin the bileacidcompositionofbileovertimemay
affecttherelativeproportionsof the various calcium salts that will belaid down in developing gallstones. This hypothesis couldpartially explainthedifferences incompositionobserved inmoving fromthecenter tothesurface inmanygallstones (2).
Finally, weemphasizethat the effect of bile acidson the
precipitationofcalcium saltscannotbeconsidered in isolation, butmusteventuallybeintegratedintoamorecomprehensive model inwhich the roleofothercomponentsofbile, suchas
phospholipids (32)andglycoproteins(3), and thepresenceof distinct microenvironments within the gallbladder (2) are
takenintoaccount.
WewishtothankAlice Cullu for editorialassistance,and Dr. Nancy Alcockforperformingthe totalcalciumdeterminations.
Thisstudywas supportedin part bygrant AM-16549 from the National Institutes of Health and grants from the Sealy and Smith Foundation.
References
1.Womack,N.A.,R.Zeppa,and G. L.Irvin. 1963. The anatomy of
gall-stones. Ann.Surg.157:670-686.
2.Crowther,R.S.,and R.D.Soloway.1990.Pigment gallstone pathogenesis:
fromman tomolecules. Semin. Liver Dis. 10:171-180.
3.Shimizu, S.,B.Sabsay,A.Veis,J. D.Ostrow,R. V.Rege,and L.G.Dawes.
1989. Isolationofanacidicproteinfrom cholesterolgallstones,which inhibits the
precipitationof calcium carbonate in vitro. J.Clin.Invest.84:1990-1996. 4.Angelico, M.,S. C. DeSanctis,C.Gandin,and D. Alvaro.1990.
Spontane-ousformation ofpigmentaryprecipitatesinbilesalt-depletedratbile and its
prevention bymicelle-formingbile salts.Gastroenterology.98:444-453.
5.Sutor,D.J.,and J. M.Percival. 1976. Presenceorabsenceof inhibitors of
crystal growthinbile.1.Effectof bileontheformation of calciumphosphate,a
constituent ofgallstones.Gut.17:506-510.
6.Eanes,E.D.,J. D.Termine,and M. U.Nylen.1973.Anelectron
micro-scopic studyof the formationofamorphouscalciumphosphateandits
transfor-mationtocrystallineapatite.Calcif Tissue Res.12:143-158.
7. Van DerMeer, R.,andH. T. DeVries. 1985. Differentialbindingof
glycine-andtaurine-conjugatedbile acidstoinsolublecalciumphosphate.
Bio-chem.J. 229:265-268.
8.Crowther,R.S.,S.-M.Qiu,G.Wen,N.Alcock,N.-K.Hong,and R. D.
Soloway.1990.Aturbidimetricstudyof theprecipitationof calciumphosphate.
Gastroenterology.98:A245.(Abstr.)
9.Crouch,S.R.,andH.V.Malmstadt. 1967.Amechanisticinvestigationof
molybdenum blue method for determination ofphosphate. Anal. Chem. 39:1084-1089.
10.Chattopadhyay,A.,andE. London.1984.Fluorimetricdetermination of critical micelle concentrationavoidinginterference fromdetergent charge.Anal. Biochem. 139:408-412.
11.Lichtenberg, D.,E.Werker,A.Bor,S.Almog,and S. Nir. 1988. Precipita-tionof calciumpalmitatefrom bilesalt-containing dispersions. Chem. Phys. Lipids.48:231-243.
12.Williams, G.,andJ. D. Sallis. 1982. Structural factorsinfluencingthe
abilityofcompoundstoinhibithydroxyapatiteformation. Cakif Tissue Int. 34:169-177.
13.Roda, A.,A.F.Hofmann,andK.J.Mysels.1983. Theinfluenceof bile saltstructureonself-associationin aqueous solutions.J.Biol.Chem. 258:6362-6370.
14.Small, D. M. 1971. The physical chemistry of cholanic acids. In The Bile Acids, Volume I. P. P. Nair and D. Kritchevsky, editors. Plenum Press, New York.249-356.
15.Termine, J. D., and D. R. Lundy. 1974. Vibrational spectra of some phosphate salts amorphous to X-ray diffraction. Calcif Tissue Res. 15:55-70.
16.Nancollas, G. H. 1984. Crystallization in bile. Hepatology(Baltimore).
4:169S-172S.
17.Boskey, A. L., and A. S. Posner. 1976. Formation of hydroxyapatite at low
supersaturation.J.Phys. Chem.80:40-45.
18.Termine, J. D., andE.D. Eanes. 1972.Comparativechemistryof amor-phousandapatitic calcium phosphate preparations.CalcifTissueRes.
10:171-197.
19.West, V. C. 1971.Observations on phase transformation ofaprecipitated calcium phosphate.CalcifTissue Res.7:212-219.
20. Eanes, E. D., andA.S.Posner. 1965.Kinetics and mechanismof
conver-sionof noncrystalline calcium phosphatetocrystallinehydroxyapatite. Trans.
N.Y.Acad.Sci.28:233-241.
21. Cheng, P.-T., and K. P. H. Pritzker. 1983. Solution Ca/P ratio affects
calciumphosphate crystal phases.CalcifTissueInt. 35:596-601.
22. Eanes, E. D., and J. L. Meyer. 1977. The maturation ofcrystalline calcium phosphates in aqueous suspensions at physiologic pH. Calcif Tissue Res. 23:259-269.
23. Tung, M.S., and W. E. Brown. 1983. An intermediate state in hydrolysis of amorphous calcium phosphate. Calcif Tissue Int. 35:783-790.
24. Moore, E.W., L.Celic, and J. D. Ostrow. 1982. Interactions between ionized calcium and sodium taurocholate: bile salts are important buffers for prevention ofcalcium-containinggallstones.Gastroenterology. 83:1079-1089.
25.Rajagopalan, N., and S.Lindenbaum. 1984. Counter-ion binding by bile acidsolutions.Hepatology (Baltimore).4:110S-1 14S.
26.Blumenthal, N. C., A. S. Posner, L. D. Silverman, and L. C. Rosenberg. 1979.Effect ofproteoglycans on in vitro hydroxyapatite formation.CalcifTissue Int.27:75-82.
27. Van Den Berg, C. J., L. F.Hill, and S. W. Stanbury. 1972. Inositol phos-phates andphytic acid as inhibitorsofbiological calcification in the rat. Clin. Sci.
(Oxf).43:377-383.
28. Root, M. J. 1990.Inhibition of the amorphous calcium phosphate phase
transformation reaction by polyphosphates and metal ions.Calcif Tissue Int. 47:112-116.
29.Termine, J. D., and K. M. Conn. 1976. Inhibition ofapatite formation by phosphorylated metabolites and macromolecules.Calcif Tissue Res. 22:149-157.
30.Fleisch, H., and S. Bisaz. 1962. Isolation from urine of pyrophosphate, a calcificationinhibitor. Am. J. Physiol. 203:671-675.
31.Termine, J. D., R. A. Peckauskas, and A. S. Posner. 1970. Calcium phos-phateformation invitro II. Effects of environment on amorphous-crystalline transformation. Arch. Biochem.Biophys. 140:318-325.
32.Wuthier, R. E., and E. D. Eanes. 1975. Effect of phospholipids on the transformation of amorphous calcium phosphate to hydroxyapatite in vitro. Cal-cif Tissue Res. 19:197-210.
33.Williams, G., and J. D. Sallis. 1979. Structure-activity relationship of inhibitors of hydroxyapatite formation. Biochem. J. 184:181-184.
34. Hay, D. I., E. C. Moreno, and D. H. Schlesinger. 1979. Phosphoprotein-inhibitors of calcium phosphateprecipitationfromsalivarysecretions. Inorg. Perspect.Biol.Med. 2:271-285.
35. Moore, E. W.,A.F. Hofmann, C. D. Schteingart, and H.-T. Ton-Nu. 1990.High-affinity premicellarCa++-bindingtobile salts:II. Structure-activity relationships. Hepatology (Baltimore). 12:998. (Abstr.)
36. Tew, W. P., C. Mahle, J.Benavides,J. E.Howard,and A. L. Lehninger. 1980.Synthesis and characterization of phosphocitric acid,apotent inhibitorof hydroxyapatite crystal growth. Biochemistry. 19:1983-1988.
37.Crowther,R.S.,N.-K.Hong,S.-M.Qiu,and R. D.Soloway.1991. Glyco-chenodeoxycholic acid inhibits calcium hydroxyapatite formation by competeti-vely inhibiting HP04- binding to the particle surface. Gastroenterology.
100:A733.(Abstr.)
38.Qiu, S.-M., R. S. Crowther, and R. D. Soloway. 1991. The ability of bile acidstoinhibit calciumhydroxyapatiteformation is reflected in their apatite
bindingaffinity.Gastroenterology. 100:A787.(Abstr.)
39. Hong, N.-K., R. D.Soloway, R. S.Crowther, F.Liu,S.-M.Qiu, H. Guo,
N.Alcock, and J.-G. Wu. 1990.Chenodeoxycholateconjugatesare more
effec-tivethantaurocholate ininhibitingtheprecipitation of calcium bilirubinate.